***Introduction.*** The authors of these bulletins are infectious diseases physicians on the front line in the epidemic of severe acute respiratory syndrome (SARS) in Hong Kong. They are affiliated with the Division of Infectious Disease, Department of Microbiology, at Queen Mary Hospital and the University of Hong Kong, and they are also caring for patients in the Pamela Youde Nethersole Eastern Hospital, Princess Margaret Hospital, and Kwong Wah Hospital. Their bulletins are being published in the News section of the electronic edition of *Clinical Infectious Diseases* within 1--2 days after receipt in our office; below is a condensation of the bulletins for 18--26 April 2003.---*Sherwood Gorbach and Michael Barza*

***Bulletin.*** On 22 March, an exposure outbreak of community-acquired SARS occurred at the Amoy Garden housing development; \>300 people were affected. In comparison with the first 300 patients seen at the begining of the outbreak in Hong Kong, these patients had a much more severe clinical course; the intubation rate was nearly 20%. Epidemiological investigation cannot explain completely the pattern of distribution of cases. However, the fact that one-third of the cases were concentrated in one housing block can be reasonably explained by a faulty sewage system and the negative pressure generated by the exhaust fan in a very small toilet facility. The wastewater from the floor of the bathroom and the bathtub drains into the sewage system. The U-shaped pipe that usually stops fecal sewage from reentering the bathroom drains did not contain a column of nonfecal wastewater and thus allowed the reflux of fecal vapor or the climbing of cockroaches (which are passive carriers of coronavirus) into the bathroom. Droplets and/or vapor from the wastewater drain are being sucked into the bathroom, which is only 6.3 m^2^ in size, by an exhaust fan.

It is interesting that coronavirus can be detected in cockroach and rat droppings by RT-PCR. The cockroach or rat ingests the virus, and the virus is then excreted with the droppings. However, no evidence of infection can be found by serological or histopathological testing of such rats. These pests probably have acted as passive carriers of the disease.

Coronavirus can be demonstrated in stool samples obtained from more than two-thirds of the patients who have coronavirus pneumonia. The low attack rate (\<5%) among household contacts of patients with SARS basically rules out airborne transmission. But this outbreak has established the possibility of fecal-oral transmission. Also of interest, more than one-half of the patients developed diarrhea during hospitalization, and health care workers who acquired infection from these patients also developed pneumonia and diarrhea. This combination of symptoms was not observed in the first 300 cases; it could be explained by a mutated or recombined variant of the coronavirus.

Because we know very little about the behavior of this virus, every single step in the management of patients who have SARS is controversial. In the beginning, we had only a clinical definition, which included significant fever, cough or shortness of breath, new radiographic infiltrates, and either an epidemiological history of exposure or a failure to respond to antibiotic therapy active against typical and atypical pneumonic agents. With the successful isolation of the coronavirus, we now have 2 new weapons for making a more accurate diagnosis---namely, RT-PCR and immunofluorescent antibody detection (the latter only for retrospective diagnosis).

What is disappointing is that RT-PCR can only detect infection in up to 50% of the patients at presentation who have subsequently had seroconversion. Additional prospective studies have shown that the virus can be found by RT-PCR analysis of stool, saliva, and urine specimens. Now there is increasing optimism that the diagnosis can be much more sensitive by testing multiple specimens from various sites.

As happens with any newly discovered condition, the mood of the medical community and of the public is swinging from pessimism to optimism. The same fluctuations are seen in the level of enthusiasm for the use of various antiviral agents, such as ribavirin, protease inhibitors, and interferon, either with conventional dosing or with modified dosing. Conclusive information on these regimens will not be available until more data are generated by carefully designed trials. It is very important for experts in health information to evaluate any new findings and disseminate them to the public, especially at a stage when nothing is really conclusive. This will prevent unnecessary panic or unrealistic expectations.---*V. C. C. Cheng, M. Peiris, and K. Y. Yuen*
